“…even when faced with consequences, subjects continue to pursue the drug) (Hu et al, 2019), the possibility of using rTMS to stimulate hypoactive prefrontal cortical neurons, which can then modulate interconnected networks, is appealing (Diana et al, 2017;Madeo and Bonci, 2019;Song et al, 2019). An increasing number of studies have shown anticraving effects following rTMS treatment targeting the PFC (see Ma et al, 2019;Madeo and Bonci, 2019;Zhang et al, 2019), presumably through modulation of the efferent glutamatergic and afferent dopaminergic connections (Diana, 2011;Diana et al, 2017; Figure 1). Therefore, rTMS modulation of mesocorticolimbic pathways in people with substance use disorders may provide therapeutic effects.…”